Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Clinical Laserthermia Systems AB Company Overview 5

Clinical Laserthermia Systems AB Company Snapshot 5

Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview 5

Clinical Laserthermia Systems AB – Pipeline Analysis Overview 8

Business Description 8

Clinical Laserthermia Systems AB - Key Facts 8

Clinical Laserthermia Systems AB - Major Products and Services 9

Clinical Laserthermia Systems AB Pipeline Products by Development Stage 10

Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status 14

Clinical Laserthermia Systems AB Pipeline Products Overview 16

CLS Cancer Immunotherapy System - Prostate Cancer 16

CLS Cancer Immunotherapy System - Prostate Cancer Product Overview 16

CLS Cancer Immunotherapy System - Prostate Cancer Clinical Trial 17

imILT Software 18

imILT Software Product Overview 18

imILT Software Clinical Trial 19

TRANBERG Cancer Immunotherapy System - Breast Cancer 20

TRANBERG Cancer Immunotherapy System - Breast Cancer Product Overview 20

TRANBERG Cancer Immunotherapy System - Breast Cancer Clinical Trial 21

TRANBERG Cancer Immunotherapy System - Pancreatic Cancer 22

TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Product Overview 22

TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Clinical Trial 23

TRANBERG Cancer Immunotherapy System - Skin Cancer 24

TRANBERG Cancer Immunotherapy System - Skin Cancer Product Overview 24

TRANBERG Cancer Immunotherapy System - Solid Cancers 25

TRANBERG Cancer Immunotherapy System - Solid Cancers Product Overview 25

TRANBERG Cancer Immunotherapy System - Solid Cancers Clinical Trial 26

Clinical Laserthermia Systems AB - Key Competitors 27

Clinical Laserthermia Systems AB - Key Employees 28

Clinical Laserthermia Systems AB - Key Employee Biographies 29

Clinical Laserthermia Systems AB - Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Clinical Laserthermia Systems AB, Recent Developments 31

Jun 18, 2018: CLS receives new order for single use products from UTMB in the U.S., for treatment of early stage prostate cancer 31

Apr 19, 2018: First patients treated with CLS TRANBERG-system in the clinical study at Toronto General Hospital, Canada 31

Apr 19, 2018: CLS participates with hands-on workshop at the European Conference on Interventional Oncology 31

Apr 17, 2018: Clinical Laserthermia Systems and Toronto General Hospital Begin Clinical Study for MRI-Guided Laser Ablation Treatment of Prostate Cancer 32

Apr 11, 2018: Clinical Laserthermia Systems Exhibits MRI-Guided Laser Ablation System at Southwest Prostate Cancer Symposium 32

Apr 04, 2018: CLS quality processes received good marks by American authority FDA 32

Mar 16, 2018: CLS and Toronto General Hospital, Canada, carry out clinical study regarding MRI guided FLA treatment of prostate cancer 33

Mar 14, 2018: CLS receives new order for the TRANBERG-system from UTMB in the U.S. 33

Mar 08, 2018: CLS imILT treatment of pancreatic cancer shows positive trend regarding survival 33

Jan 02, 2018: CLS single use accessories evaluated by Laser Prostate Centers of America 34

Appendix 35

Methodology 35

About GlobalData 38

Contact Us 38

Disclaimer 38

Summary

Clinical Laserthermia Systems AB (CLS) develops and markets systems and single-use instruments for the treatment of solid cancer tumors. The company's flagship product TRANBERG, a cancer immunotherapy system consists of a mobile laser unit and single-use products developed to perform a precise and safe treatment. It also comprises a laser applicator with introducer that is used for positioning of the fiber, depending on the tumor size. TRANBERG is developed for immune stimulating interstitial thermotherapy (imILT). CLS is also evaluating its products for treating focal laser ablation and other combined therapies. The company offers its products to hospitals and clinics. CLS is headquartered Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Clinical Laserthermia Systems AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company